Portfolio strategies of life science venture capital firms in the USA and Europe

Motivated by the different development stages of both, the venture capital (VC) as well as the life science industry in the USA and Europe, we investigate portfolio strategies of US-American and European VC firms active in this sector. We analyse portfolios of 88 VCs financing a total of 1050 life science ventures. Our results show that US life science VCs are equally likely to have a focus on early stage ventures and to diversify across investment stages as their European counterparts...

MoreLess

Year of publication:	2005
Authors:	Patzelt, Holger ; Knyphausen-Aufsess, Dodo zu ; Habib, Yasmin
Institutions:	Max-Planck-Institut für Ökonomik <Jena>
Subject:	Risikokapital \| risk capital \| Gesundheit \| health management \| Portfolio Selection

Check Google Scholar |

More access options

In German libraries (KVK)

I need help

More details

Extent:	368640 bytes 42 p. application/pdf
Series:	Max-Planck-Institut für Ökonomik - Abteilung Entrepreneurship, Growth and Public Policy Discussion Papers on Entrepreneurship, Growth and Public Policy ; 3105
Type of publication:	Book / Working Paper
Language:	English
Classification:	Corporate finance and investment policy. General ; Individual Working Papers, Preprints ; No country specification
Source:	USB Cologne (business full texts)

Persistent link: https://www.econbiz.de/10005864988